The CenterWatch Weekly, February 13, 2017
Parexel acquires The Medical Affairs Company to leverage SMLs and expand in international markets
The Medical Affairs Company (TMAC), a full-service CRO for the medical device and pharmaceutical industries, has recently been acquired by Parexel, a worldwide biopharmaceutical clinical trials company. Parexel intends to utilize many of the current services offered by TMAC, including medical science liaisons (MSLs) and clinical nurse educators.
A cautiously optimistic healthcare M&A outlook for 2017
Although 2016 was a lackluster year for megadeals in healthcare, a recent flurry of big deals has Wall Street investors cautiously optimistic that 2017 will bring new mergers and big-ticket acquisitions. An increasingly competitive landscape in healthcare, coupled with signs that the new U.S. presidential administration may usher in more business-friendly policies, could spur major deals in the upcoming year.
To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.